Explore mission critical vaccine development updates

The recent H1N1 flu pandemic has further illustrated the necessity to quickly develop vaccines in response to a global health crisis. The Vaccines Development Forum has added all new content to address rapid vaccine product in response to the world’s current pandemic. Explore the most mission critical updates and advances in the H1N1 flu vaccine rapid development with case studies and expertise from The National Institute of Health, GlaxoSmithKline, Vical, and CSL Limited.

Register today to get real time access to the industry’s response to the latest global health crisis and cutting-edge case studies on developing innovative and profitable vaccines to shave years off of your vaccine development timelines.

To connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.

Share this article with your social network, just click below to share now!

Share |